|
US2464284A
(en)
*
|
1943-10-18 |
1949-03-15 |
Smith Kline French Lab |
Vasoconstrictor composition
|
|
DE1121054B
(de)
*
|
1960-11-23 |
1962-01-04 |
Merck Ag E |
Verfahren zur Herstellung eines neuen Imidazolinderivates und dessen Saeureadditionssalzen
|
|
US3681459A
(en)
*
|
1970-10-01 |
1972-08-01 |
Armour Pharma |
Guanidine compounds and use of same
|
|
US3925344A
(en)
*
|
1973-04-11 |
1975-12-09 |
Community Blood Council |
Plasma protein substitute
|
|
US4001401A
(en)
*
|
1975-02-02 |
1977-01-04 |
Alza Corporation |
Blood substitute and blood plasma expander comprising polyhemoglobin
|
|
US4053590A
(en)
*
|
1975-02-27 |
1977-10-11 |
Alza Corporation |
Compositions of matter comprising macromolecular hemoglobin
|
|
JPS52128205A
(en)
*
|
1976-04-16 |
1977-10-27 |
Green Cross Corp:The |
Prophylactic and therapeutic drugs for cerebro-vascular contraction
|
|
DE2617493C3
(de)
*
|
1976-04-22 |
1979-03-01 |
The Green Cross Corp., Osaka (Japan) |
Verwendung von Haptoglobin oder Hämoglobin-Haptoglobin-Komplexen bei der Prophylaxe und Therapie von zerebralen Vasospasmen
|
|
US4757052A
(en)
*
|
1982-09-03 |
1988-07-12 |
Markov Angel K |
Method of preserving blood
|
|
US4529719A
(en)
*
|
1983-05-04 |
1985-07-16 |
Tye Ross W |
Modified crosslinked stroma-free tetrameric hemoglobin
|
|
GB8328917D0
(en)
*
|
1983-10-28 |
1983-11-30 |
Fisons Plc |
Blood substitute
|
|
US4598064A
(en)
*
|
1984-06-27 |
1986-07-01 |
University Of Iowa Research Foundation |
Alpha-alpha cross-linked hemoglobins
|
|
USRE34271E
(en)
*
|
1984-06-27 |
1993-06-01 |
University Of Iowa Research Foundation |
Production of alpha-alpha cross-linked hemoglobins in high yield
|
|
US4600531A
(en)
*
|
1984-06-27 |
1986-07-15 |
University Of Iowa Research Foundation |
Production of alpha-alpha cross-linked hemoglobins in high yield
|
|
US5194590A
(en)
*
|
1986-06-20 |
1993-03-16 |
Northfield Laboratories, Inc. |
Acellular red blood cell substitute
|
|
US4826811A
(en)
*
|
1986-06-20 |
1989-05-02 |
Northfield Laboratories, Inc. |
Acellular red blood cell substitute
|
|
US5464814A
(en)
*
|
1986-06-20 |
1995-11-07 |
Northfield Laboratories, Inc. |
Acellular red blood cell substitute
|
|
FR2600894B1
(fr)
*
|
1986-07-02 |
1989-01-13 |
Centre Nat Rech Scient |
Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
|
|
JP2531661B2
(ja)
*
|
1987-02-25 |
1996-09-04 |
味の素株式会社 |
酸素運搬剤
|
|
US5449759A
(en)
*
|
1987-05-16 |
1995-09-12 |
Somatogen, Inc. |
Hemoglobins with intersubunit desulfide bonds
|
|
US5268500A
(en)
*
|
1987-06-15 |
1993-12-07 |
Montefiore Medical Center |
Compound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregation
|
|
US4994444A
(en)
*
|
1987-07-31 |
1991-02-19 |
The Trustees Of Columbia In The City Of New York |
Macromolecules for sealing capillary endothelial junctions
|
|
US4988515A
(en)
*
|
1988-01-28 |
1991-01-29 |
The Regents Of The Univ. Of Calif. |
Cardioplegic solution
|
|
FR2630329B1
(fr)
*
|
1988-04-20 |
1991-07-05 |
Merieux Inst |
Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
|
|
IL87708A
(en)
*
|
1988-09-08 |
1994-04-12 |
Technion Inst For Research And |
Hemoglobin-based blood substitute possessing a colloid oncotic pressure substantially similar to human blood and method for the preparation thereof
|
|
IL87707A
(en)
*
|
1988-09-08 |
1994-06-24 |
Technion Inst For Research And |
Hemoglobin-based blood substitute substantially similar to human blood and method for preparation thereof
|
|
US5128452A
(en)
*
|
1989-04-19 |
1992-07-07 |
Baxter International Inc. |
Process for the production of crosslinked hemoglobin in the presence of sodium tripolyphosphate
|
|
DK0431129T3
(da)
*
|
1989-06-15 |
1996-06-17 |
Rorer Int Overseas |
Fremgangsmåder til inaktivering af virus i viruskontaminerede farmaceutiske præparater
|
|
US5059712A
(en)
*
|
1989-09-13 |
1991-10-22 |
Cornell Research Foundation, Inc. |
Isolating aminoarginine and use to block nitric oxide formation in body
|
|
US5370870A
(en)
*
|
1989-10-06 |
1994-12-06 |
Genentech, Inc. |
Method for protection against reactive oxygen species
|
|
US5173426A
(en)
*
|
1989-10-06 |
1992-12-22 |
Yale University |
DNAs encoding genetically engineered low oxygen affinity mutants of human hemoglobin
|
|
US5478806A
(en)
*
|
1989-11-22 |
1995-12-26 |
Enzon, Inc. |
Enhancement of antitumor therapy with hemoglobin-based conjugates
|
|
US5386014A
(en)
*
|
1989-11-22 |
1995-01-31 |
Enzon, Inc. |
Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
|
|
ATE136466T1
(de)
*
|
1989-12-29 |
1996-04-15 |
Univ Texas Tech |
Polyhämoglobin durch purinderivate und glutathion stabilisiert
|
|
US5439882A
(en)
*
|
1989-12-29 |
1995-08-08 |
Texas Tech University Health Sciences Center |
Blood substitute
|
|
US5432191A
(en)
*
|
1990-02-12 |
1995-07-11 |
The Center For Innovative Technology |
Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
|
|
US5290803A
(en)
*
|
1990-02-12 |
1994-03-01 |
The Center Of Innovative Technology |
Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
|
|
US5049695A
(en)
*
|
1990-02-12 |
1991-09-17 |
Center For Innovative Technology |
Allosteric hemoglobin modifiers
|
|
US5248785A
(en)
*
|
1990-02-12 |
1993-09-28 |
Virginia Commonwealth University |
Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
|
|
US5382680A
(en)
*
|
1990-12-07 |
1995-01-17 |
The Center For Innovative Technology |
Allosteric hemoglobin modifier compounds
|
|
US5122539A
(en)
*
|
1990-02-12 |
1992-06-16 |
Center For Innovative Technology |
Allosteric hemoglobin modifiers useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
|
|
CA2036770C
(en)
*
|
1990-02-26 |
2003-09-09 |
Jeffrey P. Whitten |
Inhibitors of nitric oxide biosynthesis
|
|
US5248766A
(en)
*
|
1990-08-17 |
1993-09-28 |
Baxter International Inc. |
Oxirane-modified hemoglobin based composition
|
|
JP3437572B2
(ja)
*
|
1991-02-12 |
2003-08-18 |
テキサス・テック・ユニバーシティー・ヘルス・サイエンシズ・センター |
改良された人工血液
|
|
ZW1992A1
(en)
*
|
1991-02-25 |
1993-09-22 |
Janssen Pharmaceutica Nv |
4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
|
|
WO1992020369A1
(en)
*
|
1991-05-14 |
1992-11-26 |
Dana Farber Cancer Institute |
Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents
|
|
US5295944A
(en)
*
|
1991-05-14 |
1994-03-22 |
Dana-Farber Cancer Institute |
Method for treating a tumor with ionizing radiation
|
|
US5334706A
(en)
*
|
1992-01-30 |
1994-08-02 |
Baxter International |
Administration of low dose hemoglobin to increase perfusion
|
|
US5296466A
(en)
*
|
1992-02-19 |
1994-03-22 |
Board Of Regents, The University Of Texas System |
Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
|
|
AU2198592A
(en)
*
|
1992-02-20 |
1993-09-13 |
Alliance Pharmaceutical Corporation |
Inhibition of bacterial endotoxin
|
|
CA2101361A1
(en)
*
|
1992-08-27 |
1994-02-28 |
Robert A. Snow |
Low diol polyalkylene oxide biologically active proteinaceous substances
|
|
NZ262679A
(en)
*
|
1993-02-22 |
1997-08-22 |
Vivorx Pharmaceuticals Inc |
Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
|
|
AU6523194A
(en)
*
|
1993-03-26 |
1994-10-24 |
Biorelease Technologies, Inc. |
Compositions including heme-containing proteins and methods relating thereto
|
|
TW381022B
(en)
*
|
1993-08-16 |
2000-02-01 |
Hsia Jen Chang |
Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
|
|
DE4338812A1
(de)
*
|
1993-11-15 |
1995-05-18 |
Braun Melsungen Ag |
Verwendung von Lösungen von vernetztem Hämoglobin zur Bekämpfung des septischen und hämorrhagischen Schocks bei Säugetieren
|
|
AU692249B2
(en)
*
|
1994-03-28 |
1998-06-04 |
Baxter International Inc. |
Therapeutic use of hemoglobin in the treatment of blood vessel blockage
|
|
NZ305258A
(en)
*
|
1995-03-23 |
2000-10-27 |
Biopure Corp |
Stable polymerised haemoglobin blood-substitute to treat or prevent hypoxia resulting from blood loss
|